News Endurance Sports Inspire Young Frenchman With RRMS Endurance Sports Inspire Young Frenchman With RRMS by Hawken Miller | February 7, 2022 Share this article: Share article via email Copy article link Armand Thoinet on his handbike. (Photo courtesy of Armand Thoinet) Sports was a huge part of Armand Thoinetās life, and when he was diagnosed with relapsing-remitting multiple sclerosis (MS) one week before his 19th birthday, that life turned upside down. He could no longer engage in activities that mattered greatly to him, such as rugby, tennis, and skiing. āI didnāt accept my illness immediately; it took about three years for me to begin to react,ā said Thoinet, 28, a native of Villeurbanne, a suburb of Lyon, France, in an interview with Multiple Sclerosis News Today. During those three dark years, Thoinet came to two realizations. He needed to focus on the positives of life and return to sports, both of which could help him manage the disease. āI realized that talking only about negatives, hammering at people about all that had been taken away, wasnāt of any help to me or anyone else,ā Thoinet said. āI switched my focus to the positives, to what my disease could bring to me and to others with movement difficulties.ā Armand Thoinet taking on a kayak challenge. (Photos Ā courtesy of Armand Thoinet) With that mindset, Thoinet regularly gives talks at schools, conferences and elsewhere about his difficult journey with MS and how people with disabilities can be treated better. At the same time, heās chasing after personal and world records in endurance sports, including adaptive biking, kayaking, walking, and paddle boating, to help raise money for MS research. In August 2019, Thoinet said he and three others set a world record as the first physically disabled group to kayak past the 80th parallel north in the Arctic.Ā They were accompanied by four healthy people, two guides, and a cameraman. COVID-19 has limited Thoinetās ability to participate in similar endurance events, but like everything else in his life, he found a workaround. He and five friends did a stationary bike relay for a week ā 24 hours each day in four-hour shifts ā to raise money for the AFM TĆ©lĆ©thon,Ā which supports rare disease research and care. Thoinet and all except one rode hand-bike home trainers, traveling a combined 3,600 km (2,237 miles) and raising a total of about ā¬4,500 (about $5,152). Recommended Reading December 9, 2021 News by Margarida Maia, PhD Sensorimotor Exercise Linked to Better Overall Quality of Life Last year, Thoinet and a friend rode a tandem bike 1,010 km across France in 10 days, and he and his sisters participated in a five-day hike through Auvergne. Thoinet set up a nonprofit association, called Les dĆ©fis dāArmandĀ (Armand’s Challenges) in 2015, which has raised a total of $23,000 for research-focused MS organizations. Most of the funds go to the ARSEP Foundation, which translates to the Foundation for Research on Multiple Sclerosis, though it also has sent money to EDMUS (European Database for Multiple Sclerosis), collected and stored at a center in Lyon, whose patient records are used to advance care and disease research. Participating and training for these activities has helped to overcome some MS symptoms, Thoinet said. When he was diagnosed about 10 years ago, he could walk only 200 meters (220 yards), but with muscle strength gained through his active lifestyle, he says he now can āwalk without limit.ā āIf I stopped my sports training and my challenges, I know that every walking problem I had will reappear,ā Thoinet said. āI must do sports ā but for me, that’s not a problem. I love it!ā Exercise and MS Some research backs up the importance of exercise in MS. A 2020 study funded by The National MS Society, which took guidance from experts in MS, exercise, rehabilitation, and physical activity, recommended that healthcare providers promote exercise and a healthy lifestyle. For milder cases of MS, they suggested aerobic and resistance training two to three times a week, daily flexibility exercise, and neuromotor exercise three to six times a week. Thoinet started with rigorous daily training, but realized he wasnāt listening to his body and needed to take time off every now and then. There are periods when he exercises every day, and others where he works out only once or twice a week. He pairs his physical activity with a once-every-six-month infusion of Ocrevus (ocrelizumab), a monoclonal antibody developed by Genentech andĀ approved for use in the European Union in January 2018. Armand talking with a group of young people as part of his volunteer work. While Thoinet is extremely active, he doesnāt necessarily recommend the same level for others with MS. But he does encourage people to push themselves as much as they safely can. Participating in theater, for example, forces Thoinet out his comfort zone in a non-physical way ā difficulties with speaking and articulating are among his most bothersome disease symptoms. āThe point is to attempt to do things. Attempt despite your failures. Attempt in spite of your successes,ā Thoinet said. āThe more we try, the more we learn we can do. The principle is to be daring, to go after whatever you imagine you want to do.ā Thoinet still struggles with other MS symptoms, particularly problems with his vision, hearing, and fatigue. But his balance remains strong. Speech difficulties have made it harder to engage in his volunteer work, where he gives inspirational speeches at conferences and, particularly, at schools. He focuses on the message of shared humanity, disabled or not. āTalking with young people about what itās like to be different is important to me. I want to show that being different can also be an opportunity,ā Thoinet said. āVolunteering is at the center, the core, of my resurrection with this disease. I volunteer to help young people and share a message of what it means to be human, in the most positive way.ā In a professional setting, he provides peer support for the Lyon Association for the Management of Institutions for Disabled People and serves as anĀ ambassador for outdoor sports with the Department ofĀ IsĆØre, a part (akin to a county and its governance in the U.S.) of the Auvergne-RhĆ“ne-Alpes region of France and close to his home. Thoinet also is showing a documentary about his challenges, āEnsemble au bout de mondeā (āTogether to the End of the Earthā). In the next few months, he plans to bring the film to five nearby cities. His next planned endurance sport event will take Thoinet on a 650 km pedal boat tour of Corsica, a mountainous island off the southern coast of France. It will count as a world record if realized, he said. Thoinet also plans to participate in a triathlon in October. Even with all of the challenges associated with MS, Thoinet has been able to thrive in his role as a disability advocate, endurance athlete, and inspirational speaker. He believes he can be an example to others, whether they are disabled or not, helping them to manage whatever life throws their way. āYoung people are able to arrive at an understanding of what Iāve overcome. They donāt have the same problems as me, but theyāve other problems,ā Thoinet said. āThey start to realize that if Armand can accomplish what he has, given what heās up against, then I, too, can find a path to succeed.ā Print This Page About the Author Hawken Miller Hawken graduated from the University of Southern California (USC) in 2019. Before joining BioNews, he wrote for the Washington Postās video game and esports section, Launcher, where he still contributes as a freelancer. Hawken is also a columnist for BioNews, focusing on his experience with Duchenne muscular dystrophy for Muscular Dystrophy News Today. His work has appeared in Dot Esports, The Orange County Register, KTLA 5, and The Sacramento Bee. He won a Webby for virtual reality journalism at USC. Tags advocacy, Ocrevus, relapsing-remitting MS, RRMS
April 23, 2024 News by Margarida Maia, PhD AAN 2024: Subcutaneous Ocrevus led to nearly no relapses after year
April 19, 2024 News by Lindsey Shapiro, PhD AAN 2024: Earlier Ocrevus lowers MS progression risk over 10 years
April 18, 2024 News by Lindsey Shapiro, PhD AAN 2024: Ocrevus benefits Black, Hispanic patients same as whites